| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 06/14/1993 | CA2085212A1 Nutritive composition for prevention and therapy of infection diseases caused by immunosuppression |
| 06/13/1993 | CA2085142A1 Stabilized pharmaceutical composition of non glycosyled recombinant human il2 in reduced form and preparation process therefore |
| 06/10/1993 | WO1993011280A1 Multiple solvent cleaning system |
| 06/10/1993 | WO1993011232A1 Ifn-gamma antagonist cytokine |
| 06/10/1993 | WO1993011122A1 Piperazine derivatives as 5-ht1a antagonists |
| 06/10/1993 | WO1993011116A1 Novel azepine derivative, production thereof, and use thereof |
| 06/10/1993 | WO1993011110A1 Preparation of substituted piperidines |
| 06/10/1993 | WO1993011106A1 Indole derivatives |
| 06/10/1993 | WO1993011099A1 Nitroaniline derivatives and their use as antitumor agents |
| 06/10/1993 | WO1993010811A1 Proteolytic mixture containing escharase and method of isolating same |
| 06/10/1993 | WO1993010810A1 Bone regeneration |
| 06/10/1993 | WO1993010808A1 INHIBITING TRANSFORMING GROWTH FACTOR β TO PREVENT ACCUMULATION OF EXTRACELLULAR MATRIX |
| 06/10/1993 | WO1993010805A1 Inhibitory immunoglobulin polypeptides to human pdgf beta receptor |
| 06/10/1993 | WO1993010802A1 Aqueous synthetic organ extracts |
| 06/10/1993 | WO1993010780A1 Heterocyclic-substituted pyridine compounds and uses |
| 06/10/1993 | CA2124948A1 Gamma ifn-antagonist cytokine |
| 06/10/1993 | CA2124591A1 Inhibiting transforming growth factor .beta. to prevent accumulation of extracellular matrix |
| 06/10/1993 | CA2123803A1 Bone regeneration |
| 06/10/1993 | CA2123207A1 Multiple solvent cleaning system |
| 06/10/1993 | CA2084542A1 Novel azaheterocyclylmethyl-chromans |
| 06/10/1993 | CA2084541A1 Piperidylmethyl-substituted chroman derivatives |
| 06/09/1993 | EP0545912A2 1-Biphenylmethylimidazole derivatives, their preparation and their therapeutic use |
| 06/09/1993 | EP0545511A2 Process for the preparation of mono-N-substituted tetraazamacrocycles |
| 06/09/1993 | EP0545425A1 2-(3-Phenylpropyl)hydrazines, intermediates in and a process for the preparation thereof, and their use as medicaments |
| 06/09/1993 | EP0545376A1 Guanidino thiazoles and their use as H2-receptor antagonist |
| 06/09/1993 | EP0545171A1 Quinolylmethoxyphenyl acetic acid acylamides and ureas |
| 06/09/1993 | EP0545147A2 Use of radical scavengers and/or substances suitable for deactivating nonradical reactive oxygen species for preventing or delaying human hair greying |
| 06/09/1993 | EP0545095A1 1,3-Substituted cycloalkenes and cycloalkanes as central nervous system agents |
| 06/09/1993 | EP0544812A1 Bisphosphonic acid derivatives as anti-arthritic agents. |
| 06/09/1993 | EP0544779A1 Heterocyclic compounds and their preparation and use |
| 06/09/1993 | EP0544756A1 1,2,5,6-tetrahydro-1-methylpyridines, their preparation and use |
| 06/09/1993 | EP0544716A1 Oligonucleotide modulation of cell adhesion |
| 06/09/1993 | EP0544681A1 A novel salicylic acid-maltol conjugates. |
| 06/08/1993 | US5218115 Cholecystokinin antagonists |
| 06/08/1993 | US5218114 Cholecystokinin antagonists |
| 06/08/1993 | US5217994 Method of inhibiting osteoclast-mediated bone resorption by administration of aminoalkyl-substituted phenyl derivatives |
| 06/08/1993 | US5217993 Monensin derivatives |
| 06/08/1993 | US5217992 Tocotrienols in the treatment of hypercholesterolemia, hyperlipidemia and thromboembolic disorders |
| 06/08/1993 | US5217978 Lipoxygenase inhibitors |
| 06/08/1993 | US5217976 Hypotensive agents, congestive heart failure |
| 06/08/1993 | US5217973 Triazolopyrimidine derivatives which are angiotensin ii receptor antagonists processes for preparing them and pharmaceutical compositions containing them |
| 06/08/1993 | US5217969 Antiinflammatory, antiulcer agent |
| 06/08/1993 | US5217968 N-alkylbenzo(b)thieno [3,2-b]oxazin-2,4-diones |
| 06/08/1993 | US5217964 Free radical scavenger; prevent cell damage |
| 06/07/1993 | CA2084640A1 Compounds |
| 06/05/1993 | CA2082668A1 Heterocyclic derivatives |
| 06/04/1993 | CA2084161A1 Quinolylmethoxyphenylacetic acid acylamides and ureas |
| 06/04/1993 | CA2084131A1 Thiazolyl-substituted quinolylmethoxyphenylacetic acid derivatives |
| 06/02/1993 | EP0544620A1 Macrocyclic lactams as inhibitors of atrial natriuretic factors (ANF)-degrading neutral endopeptidase (NEP) |
| 06/02/1993 | EP0544412A2 Rhenium and technetium complexes containing a hypoxia-localizing moiety |
| 06/02/1993 | EP0544171A1 Use of 5,6-dihydro-dibenz[b,e]azepine-6,11-dione-11-oximes for the preparation of antiretroviral agents. |
| 06/02/1993 | EP0544169A1 6-thiono-5,6-dihydro-dibenz[b,e]azepin-11-ono-oximes and their use as retroviral agents |
| 06/02/1993 | EP0544168A1 Aminoalkyl substituted 5,6-dihydro-dibenzo(b,e)azepin-6,11-dion-11-oximes |
| 06/02/1993 | EP0543936A1 Renin inhibitors |
| 06/02/1993 | EP0543922A1 Methods for inducing cell differentiation using ceramides |
| 06/02/1993 | EP0543902A1 Use of metalloporphyrins to potentiate aids therapy |
| 06/02/1993 | EP0543891A1 Diphenylurea derivatives |
| 06/02/1993 | EP0543884A1 Benzanilide derivatives and their use as anti-atherosclerotic agents |
| 06/02/1993 | EP0543861A1 Imidazopyridine derivatives, process for their preparation and their application |
| 06/02/1993 | EP0543858A1 Benzimidazole derivatives, process for their preparation and application |
| 06/02/1993 | CN1072683A 水溶性喜树碱衍生物 Water-soluble derivative of camptothecin |
| 06/02/1993 | CN1072679A 吲哚衍生物 Indole derivatives |
| 06/02/1993 | CN1072677A 芳族脒衍生物及其盐 Aromatic amidine derivatives and salts thereof |
| 06/02/1993 | CN1072601A Use of combination of angiotensin-converting enzyme inhibitor and calcium antagonist for treatment of proteinuria |
| 06/01/1993 | US5216159 Certain cycloalkyl and azacycloalkyl pyrrolopyrimidines; a new class of GABA brain receptor ligands |
| 06/01/1993 | US5216151 High yield antihistamines; dehydration |
| 06/01/1993 | US5216148 Treating, preventing neoplasms, dermatoses, aging of skin |
| 06/01/1993 | US5216022 Aromatic esters of phenylenedialkanoates as inhibitors of human neutrophil elastase |
| 06/01/1993 | US5216001 Central nervous system disorders |
| 06/01/1993 | CA1318686C Catechol derivatives, a process of preparation thereof, and therapeutical compositions containing the same |
| 06/01/1993 | CA1318670C 2-acyloxypropylamine derivatives, processes for the preparation thereof and pharmaceutical compositions containing them |
| 06/01/1993 | CA1318592C N-acetyl glucosamine as a cytoprotective agent |
| 05/29/1993 | WO1993011121A1 Benzoxazinone derivative |
| 05/29/1993 | CA2101428A1 Benzoxazinone derivative |
| 05/28/1993 | CA2083798A1 5,6-dihydro-dibenz(b,e) azepine-6,11-dione-11-oximes |
| 05/28/1993 | CA2083794A1 6-thiono-5,6-dihydro-dibenz(b,e) azepin-11-one-11-oximes |
| 05/28/1993 | CA2083771A1 Aminoalkyl-substituted 5, 6-dihydro-dibenz (b,e) azepine-6, 11-dione-11-oximes |
| 05/27/1993 | WO1993010244A1 Synthetic alpha-l-iduronidase and genetic sequences encoding same |
| 05/27/1993 | WO1993010242A1 NOVEL HUMAN cdc25 GENES, ENCODED PRODUCTS AND USES THEREFOR |
| 05/27/1993 | WO1993010235A1 Human il-4 mutant proteins |
| 05/27/1993 | WO1993010146A1 Amylin agonist peptides and uses therefor |
| 05/27/1993 | WO1993010137A1 2'-deoxy-2'-fluorocoformycin and stereoisomers thereof |
| 05/27/1993 | WO1993010115A1 Amorphous (quinolin-2-ylmethoxy) indoles as leukotriene antagonists |
| 05/27/1993 | WO1993010114A1 3-pyridinol derivatives and their use as medicaments |
| 05/27/1993 | WO1993010107A1 Phenol derivatives as agonists of a cyclic amp dependent protein kinase |
| 05/27/1993 | WO1993010093A1 2-pyridinol derivatives and their use as medicaments |
| 05/27/1993 | WO1993010092A1 1,3-substituted cycloalkenes and cycloalkanes as central nervous system agents |
| 05/27/1993 | WO1993010087A1 Derivatives of cyclic phenolic thioethers as inhibitors or stimulators of superoxide generation |
| 05/27/1993 | WO1993009812A1 MURINE MONOCLONAL ANTIBODY (5c8) RECOGNIZES A HUMAN GLYCOPROTEIN ON THE SURFACE OF T-LYMPHOCYTES |
| 05/27/1993 | WO1993009800A1 Inhibitors of cell regulatory factors and methods for preventing or reducing scarring |
| 05/27/1993 | WO1993009796A1 Use of interleukin-8 |
| 05/27/1993 | WO1993009795A1 Non-peptidic surrogates of the arg-gly-asp sequence and pharmaceutical compositions comprising them |
| 05/27/1993 | WO1993009790A1 Methods of inhibiting restenosis |
| 05/27/1993 | WO1993009785A1 Risedronate delayed-release compositions |
| 05/27/1993 | WO1993009777A1 Tocotrienols and tocotrienol-like compounds and methods for their use |
| 05/27/1993 | WO1993009776A1 Pharmaceutical compositions of gallium complexes of 3-hydroxy-4-pyrones |
| 05/27/1993 | WO1993009775A1 Unbuffered premixed ranitidine formulation |
| 05/27/1993 | WO1992000067A3 Treatment of chronic renal failure with imidazole angiotensin-ii receptor antagonists |
| 05/27/1993 | CA2378820A1 Murine monoclonal antibody (5c8) recognizes a human glycoprotein on the surface of t-lymphocytes |
| 05/27/1993 | CA2124857A1 Methods of inhibiting restenosis |